Hindustan Agrigenetics Ltd

As of June 30, 2026, Hindustan Agrigenetics Ltd carries a market capitalization of 190.09M, placing it among publicly traded companies globally. Its enterprise value stands at 190.09M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Hindustan Agrigenetics Ltd has 4.42M shares outstanding.

As of June 30, 2026, Hindustan Agrigenetics Ltd trades at a trailing price-to-earnings ratio of 574.73.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, Hindustan Agrigenetics Ltd recorded 1.60M in income tax expense. That works out to an effective tax rate of 82.95, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 1.93M, leaving 329,000.00 in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Hindustan Agrigenetics Ltd's stock has declined approximately 44.79% over the past 52 weeks. The 50-day moving average sits at 37.79, while the 200-day moving average is 43.72.

Over the twelve months ended June 30, 2026, Hindustan Agrigenetics Ltd generated - - in revenue and converted that into 329,000.00 in net income, yielding earnings per share of 0.07. EBITDA reached -2.17M, while operating income came in at -3.76M.